Neuroprotection with the Endozepine Octadecaneuropeptide, ODN - Normandie Université Access content directly
Journal Articles Current Pharmaceutical Design Year : 2018

Neuroprotection with the Endozepine Octadecaneuropeptide, ODN


The term endozepines designates a family of astroglia-secreted proteins including the diazepambinding inhibitor (DBI) and its processing products, which have been originally isolated and characterized as endogenous ligands of benzodiazepine receptors. It is now clearly established that the octadecaneuropeptide ODN (DBI33-50), acting through the central-type benzodiazepine receptor or a metabotropic receptor, exerts important functions such as proconflict behavior, induction of anxiety, inhibition of pentobarbital-provoked sleep, decrease of water consumption and reduction of food intake. To mediate its effects, ODN regulates both glial cell and neuronal activities by acting on neurosteroid biosynthesis and/or neuropeptide expression. In addition, ODN stimulates astrocyte proliferation and protects both neurons and astrocytes from oxidative stress-induced cell death. The antiapoptotic effect of ODN on neural cells is mediated through activation of the ODN metabotropic receptor positively coupled to PKA, PKC and MAPK/ERK transduction pathways, which ultimately reduces the pro-apoptotic gene Bax and stimulates Bcl-2 expressions, and inhibits intracellular reactive oxygen species accumulation. The imbalance in favor of Bcl2 promotes mitochondria functions and blocks in turn caspases activation while at the same time, ODN also activates the endogenous antioxidant system i.e. glutathione biosynthesis, and expression and activities of antioxidant enzymes. In cultured astrocytes, DBI expression is up-regulated during moderate oxidative stress, and authentic ODN production is increased, suggesting that ODN may act as a paracrine factor protecting neighboring neurons. Taken together, the remarkable effect of ODN on the apoptotic cascade suggests that innovative ODN derivatives could potentially be useful for treatment of cerebral injuries involving oxidative stress and neurodegeneration.
No file

Dates and versions

hal-02280075 , version 1 (06-09-2019)



Olfa Masmoudi-Kouki, Yosra Hamdi, Ikram Ghouili, Seyma Bahdoudi, Hadhemi Kaddour, et al.. Neuroprotection with the Endozepine Octadecaneuropeptide, ODN. Current Pharmaceutical Design, 2018, 24 (33), pp.3918-3925. ⟨10.2174/1381612824666181112111746⟩. ⟨hal-02280075⟩
86 View
0 Download



Gmail Mastodon Facebook X LinkedIn More